You are here: Industry Insights > Phlow

News List

Phlow receives approval to join BARDA CDMO network October 25, 2021
US start-up Phlow has been approved to join the Biomedical Advanced Research and Development Authority's (BARDA) CDMO network to provide domestic API manufacturing capability for essential medicines and medical countermeasures.
Collaboration to encourage US adoption of continuous manufacturing europeanpharmaceuticalreview
April 14, 2021
USP and Phlow have built a new laboratory to develop test methods and standards to facilitate broader adoption of continuous manufacturing in the US.
Phlow Corp. and USP Form Alliance contractpharma
March 02, 2021
Focused on continuous manufacturing to increase supply of essential medicines for U.S. patients.
Phlow secures $354m US contract for drug supply amid Covid-19 pharmaceutical-technology
May 21, 2020
US-based public benefit drug manufacturing corporation Phlow has received $354m funding from the government to produce essential medicines at risk of shortage amid the Covid-19 pandemic.